Table 2.
Study | Country | Design | Sample | Setting | Age, Years Mean (SD), or Median [IQR] | Female (%) | CFS Version | CFS Cut-Off | Pre-Hospital Frailty (%) |
---|---|---|---|---|---|---|---|---|---|
Anand et al 202028 | UK | P | 198 | TC | 79 (6) | 42 | 7-item | CFS ≥5 | 20 |
Bagshaw et al 201443 | Canada | P | 421 | ICU | 67 (10) | 39 | 9-item | CFS ≥4 | 33 |
Basic & Shanley 201544 | Australia | P | 2125 | TC | 83 (8) | 60 | 7-item | CFS ≥5 | 89 |
Chan et al 201929 | Canada | R | 423 | TC | 83 (8) | 63 | 9-item | CFS ≥6 | 83 |
Cheung et al 201730 | Canada | R | 260 | TC | 77 (8) | 47 | 7-item | CFS ≥6 | 14 |
Chong et al 2017, 201831,32 | Singapore | P | 206 | TC | 89 (5) | 70 | 9-item | CFS ≥5 | 81 |
Chua et al 202045 | Singapore | P | 314 | ED | 84 (7) | 60 | 9-item | CFS ≥5 | 65 |
Curtis et al 201846 | US | R | 1403 | TC | 78 (9) | NS | 7-item | NS | NS |
Darvall et al 201947 | Australia | R | 15613 | ICU | 85 [82–88] | 47 | 9-item | CFS ≥5 | 40 |
Darvall et al 20204 | Australia | P | 218 | TC | 74 [69–80] | 45 | 9-item | CFS ≥5 | 28 |
Ekerstad et al 2011, 2014, 201833–35 | Sweden | P | 307 | TC | 83 (NS); 85 (NS) | 49 | 7-item | CFS ≥5 | 49 |
Ellis et al 202036 | UK | P | 2254 | ED | 85 (14) | 55 | 9-item | CFS ≥5 | 91 |
Evans et al 201949 | UK | P | 433 | TC | 83 [77–86]; 87 [83–92] | 48–63 | 9-item | CFS ≥5 | 54 |
Fernando et al 201937 | Canada | P | 1510 | TC | 73 (7); 80 (8) | 44 | 9-item | CFS ≥5 | 34 |
Flaatten et al 201750 | ESICM | P | 5021 | ICU | 84 [81–86] | 48 | 9-item | CFS ≥5 | 43 |
Fronczek et al 201851 | Poland | P | 272 | ICU | 84 [81–87] | 59 | 9-item | CFS ≥5 | 63 |
Guidet et al 202052 | ESICM | P | 3920 | ICU | 84 [81–87] | 47 | 9-item | CFS ≥5 | 40 |
Lewis et al 201938 | Australia | P | 899 | ED | 80 (8) | 51 | 7-item | CFS ≥5 | 44 |
Li et al 201839 | Canada | P | 308 | TC | 75 [65–94] | 45 | 7-item | CFS ≥5 | 22 |
MacKenzie et al 201953 | Canada | P | 400 | TC | 81 (8) | 57 | 9-item | CFS ≥5 | 79 |
Moore et al 201840 | UK | R | 924 | TC | 85 (9); 87 (9) | 54–69 | 9-item | CFS ≥5 | 71–84 |
Ritt et al 201741 | Germany | P | 305 | TC | 85 (7); 82 (6) | 60–70 | 9-item | CFS ≥5 | 72 |
Silva-Obregon et al 202054 | Spain | R | 285 | ICU | 78 (4) | 38 | 9-item | CFS ≥5 | 19 |
Sze et al 201755 | UK | P | 265 | TC | 80 [72–86] | 38 | 9-item | CFS ≥4 | 53 |
Ticinesi et al 201956 | US | R | 118 | TC | 84 (5) | 61 | 7-item | CFS ≥5 | 45 |
Wallis et al 201542 | UK | R | 5764 | TC | 84 (6) | 56 | 9-item | CFS ≥5 | 57 |
Abbreviations: ESICM (European Society of Intensive Care Medicine) includes Austria, Belgium, Cyprus, Czech Republic, Denmark, France, Germany, Greece, Italy, Libya, the Netherlands, Norway, Poland, Portugal, Romania, Russia, Spain, Sweden, Switzerland, Turkey, United Kingdom; P, prospective; R, retrospective; ICU, intensive care unit; ED, emergency department; TC, tertiary care including specialized medical care, trauma care, surgical care, University Hospitals, or tertiary referral hospitals; NS, not stated; SD, standard deviation; IQR, interquartile range.